Loading organizations...
Agriculture technology firm developing sustainable bacterial solutions.
NewLeaf Symbiotics has raised $99.0M across 4 funding rounds.
NewLeaf Symbiotics has raised $99.0M in total across 4 funding rounds.
NewLeaf Symbiotics has raised $99.0M in total across 4 funding rounds.
NewLeaf Symbiotics's investors include Peter Odemark, Leaps by Bayer, Otter Capital, S2G Ventures, Ryan Rakestraw, John Pasquesi, Lewis & Clark Ventures, Open Prairie, Pangaea Ventures, RockPort Capital, Sanjeev Krishnan, Yard Ventures.
NewLeaf Symbiotics has raised $99.0M across 4 funding rounds. Most recently, it raised $45.0M Series D in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 20, 2023 | $45.0M Series D | Peter Odemark | Leaps by Bayer, Otter Capital, S2G Ventures |
| Sep 7, 2017 | $30.0M Series C | Ryan Rakestraw, John Pasquesi | Lewis & Clark Ventures, Open Prairie, Pangaea Ventures, RockPort Capital, Sanjeev Krishnan, Yard Ventures |
| Sep 17, 2014 | $17.0M Series B | John Pasquesi | Open Prairie, Pangaea Ventures, Daniel Hullah |
| Jan 10, 2013 | $7.0M Other Equity | Jason Wrone, Keith Gillard, Kevin Kopczynski |